Vaccin Covid Usa Moderna. Results from another 56 participants. The massachusetts biotech firm said it will ask the food and drug administration for emergency use authorization after completing its phase 3 trial, finding the vaccine was 94.1 percent.
Moderna seeks us approval for 94.1% effective vaccine. Shares rose as much as 21% after the company said the u.s. Pfizer and moderna are applying to the u.s.
Karen weintraub, usa today 11/16/2020
The results come hot on the heels of similar results from pfizer, and add to growing. The coronavirus vaccine was found to be highly effective and showed no safety issues. The massachusetts biotech firm said it will ask the food and drug administration for emergency use authorization after completing its phase 3 trial, finding the vaccine was 94.1 percent. Moderna will submit its coronavirus vaccine for regulatory approval on monday, the company said — the second leading drug to pass the milestone this month.
